Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo Di Marzo

Showing results (1-10 of 658) with videos related to

Pageof 66
Sort By:
Expert Review of Neurotherapeutics|April 1, 2011
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunctionVincenzo Di Marzo
Dialogues in Clinical Neuroscience|November 9, 2020
The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders
Vincenzo Di Marzo
Nature Reviews. Drug Discovery|May 1, 2008
Targeting the endocannabinoid system: to enhance or reduce?Vincenzo Di Marzo
Pain|July 13, 2012
Inhibitors of endocannabinoid breakdown for pain: not so FA(AH)cile, after allVincenzo Di Marzo
Gastroenterology|April 3, 2012
"De-liver-ance" from CB(1): a way to counteract insulin resistance?Vincenzo Di Marzo
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2011
Endocannabinoids: an appetite for fatVincenzo Di Marzo
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
Endocannabinoids in the new millenniumVincenzo Di Marzo
Trends in Pharmacological Sciences|February 16, 2006
A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientistsVincenzo Di Marzo
Recent Patents on CNS Drug Discovery|April 10, 2013
Different targets of anti-glucocorticoid treatment have been proposed, acting at supra-hypothalamic, HPA axis, glucocorticoid receptor and post-receptor levelsVincenzo Di Marzo
British Journal of Pharmacology|July 4, 2003
Manipulation of the endocannabinoid system by a general anaestheticVincenzo Di Marzo
Pageof 66

Showing results (1-10 of 658) with videos related to

Sort By:
Pageof 66
Expert Review of Neurotherapeutics|April 1, 2011
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunctionVincenzo Di Marzo
Dialogues in Clinical Neuroscience|November 9, 2020
The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders
Vincenzo Di Marzo
Nature Reviews. Drug Discovery|May 1, 2008
Targeting the endocannabinoid system: to enhance or reduce?Vincenzo Di Marzo
Pain|July 13, 2012
Inhibitors of endocannabinoid breakdown for pain: not so FA(AH)cile, after allVincenzo Di Marzo
Gastroenterology|April 3, 2012
"De-liver-ance" from CB(1): a way to counteract insulin resistance?Vincenzo Di Marzo
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2011
Endocannabinoids: an appetite for fatVincenzo Di Marzo
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
Endocannabinoids in the new millenniumVincenzo Di Marzo
Trends in Pharmacological Sciences|February 16, 2006
A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientistsVincenzo Di Marzo
Recent Patents on CNS Drug Discovery|April 10, 2013
Different targets of anti-glucocorticoid treatment have been proposed, acting at supra-hypothalamic, HPA axis, glucocorticoid receptor and post-receptor levelsVincenzo Di Marzo
British Journal of Pharmacology|July 4, 2003
Manipulation of the endocannabinoid system by a general anaestheticVincenzo Di Marzo
Pageof 66